|
COVID-19 and Long COVID |
![]() COVID-19 and Post COVID-19 Condition (Long COVID) |
Highlights |
- Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This entity is well known to be associated with poor responses to available treatment options and dismal outcomes.
Read More >> - Treatment of Light Chain Deposition Disease: A Systematic Review
Light chain deposition disease (LCDD) is a rare hematologic disorder that can affect any organ but predominantly involves the kidneys. Existing literature is limited to case reports and small single-center retrospective series, explaining the lack of any treatment algorithms and management guidelines for patients with this disorder.
Read More >> - Hematological, Biochemical Properties, and Clinical Correlates of Hemoglobin S Variant Disorder: A New Insight Into Sickle Cell Trait
The sickle cell trait (SCT) disorder possesses a clinical heterogeneity ranging from a symptomless condition to sudden death. This study aimed to develop a diagnostic approach that helps the characterization and identification of SCT from normal subjects and sickle cell disease (SCD) patients, and to assess its severity.
Read More >> - COVID-19-Associated Pneumonia in a B-Cell-Depleted Patient With Non-Hodgkin Lymphoma: Recovery With Hyperimmune Plasma
Coronavirus disease 2019 (COVID-19) can have a severe course in immunocompromised hosts and patients with hematological malignancies. In some cases, the bad prognosis is associated with the lack of B lymphocytes, with impaired antibody production and inefficient viral clearance.
Read More >> - Leukoerythroblastosis in a Sickle Cell Patient With Pregnancy: An Interesting Peripheral Blood Smear Finding
The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shaken the entire world. The social, health and financial impacts of this pandemic are beyond words.
Read More >>
Featured |
|
| Featured |
|
| Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis |
Key Clinical Image |
![]() Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study |
Current Issue |
|
Vol. 11, No. 6, Dec 2022
Table of Contents
Review
Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies | Abstract HTML PDF |
Zoe McKinnell![]() |
197-209 |
doi: https://doi.org/10.14740/jh1042 |
Short Communication
Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies | Abstract HTML PDF |
Anthony J. Ocon, Kate E. Ocon, Jennifer Battaglia, Soon Khai Low, Niraj Neupane, Hassan Saeed, Saad Jamshed, S. Shahzad Mustafa | 210-215 |
doi: https://doi.org/10.14740/jh1062 |
Case Report
Synchronous Presentation of Autoimmune Hepatitis and Multiple Myeloma | Abstract HTML PDF |
Binoy Yohannan, Allen C. Omo-Ogboi, Varaha S. Tammisetti, Adan Rios | 216-222 |
doi: https://doi.org/10.14740/jh1049 |
Thymoma With Triple Threat: Pure Red Cell Aplasia, Autoimmune Hemolytic Anemia, and T-Cell Large Granular Lymphocytic Leukemia | Abstract HTML PDF |
Tara Seibert, Patrick J. Loehrer, Andrew R.W. O’Brien | 223-232 |
doi: https://doi.org/10.14740/jh1061 |
Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study | Abstract HTML PDF |
Khazra Bhatti, Aqsa Nazir, Simon Ostergaard, Lone Schejbel, Peter Norgaard, Lise M.R. Gjerdrum, Mahnaz Moghaddas, Torsten H. Nielsen, Lars Munksgaard, Lars M. Pedersen | 233-239 |
doi: https://doi.org/10.14740/jh1073 |
Letter to the Editor
Unveiling the Great Therapeutic Potential of MASPs as Hemostatic Agents | Abstract HTML PDF |
Ashraf Abdullah Saad![]() |
240-245 |
doi: https://doi.org/10.14740/jh1060 |